Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 45.5 | 45.2 | 41.1 | 37.0 |
| Revenue growth | 0.7% | 9.8% | 11.3% | |
| Cost of goods sold | 13.0 | 11.7 | 10.9 | 10.5 |
| Gross profit | 32.5 | 33.4 | 30.3 | 26.5 |
| Gross margin | 71.4% | 74.0% | 73.6% | 71.6% |
| Selling, general and administrative | 51.3 | 39.0 | 27.6 | 30.2 |
| Research and development | 21.9 | 18.2 | 15.7 | 18.3 |
| EBIT | -40.8 | -23.7 | -7.8 | -22.0 |
| EBIT margin | -89.6% | -52.5% | -19.0% | -59.6% |
| Pre-tax income | -47.1 | -36.1 | -24.3 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | |
| Net income | -47.1 | -36.1 | -24.3 | 0.0 |
| Net margin | -103.4% | -79.9% | -59.0% | 0.0% |
| |
| Diluted EPS | ($1.91) | ($2.17) | ($118.97) | $0.00 |
| Shares outstanding (diluted) | 24.6 | 16.6 | 0.2 | 201.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|